Literature DB >> 16220073

Role of ATP-sensitive K+ -channels in hemodynamic effects of peroxynitrite in anesthetized rats.

Jonathan E Graves1, Stephen J Lewis, Neil W Kooy.   

Abstract

The aim of this study was to determine whether the hypotensive and vasodilator actions of peroxynitrite in pentobarbital-anesthetized rats involve the activation of ATP-sensitive K+-channels (K+ATP-channels). The effects of the K+ATP-channel agonist, cromakalim (9-36 microg/kg, iv), peroxynitrite (0.5-10 micromol/kg iv), and L-S-nitrosocysteine (12.5-200 nmol/kg, iv) on mean arterial blood pressure (MAP) and mesenteric (MR) and hindquarter (HQR) vascular resistances were determined before and after injection of the K+ATP-channel blocker, glibenclamide (40 micromol/kg, iv). Cromakalim, peroxynitrite, and L-S-nitrosocysteine produced dose-dependent reductions in MAP, MR, and HQR. Administration of glibenclamide did not affect resting hemodynamic parameters but markedly attenuated the hemodynamic actions of cromakalim. The maximal falls in MAP and HQR produced by peroxynitrite were attenuated by glibenclamide whereas the maximal falls in MR were not affected. In addition, the duration of the hypotensive and vasodilator effects of peroxynitrite in the mesenteric and hindquarter beds were markedly diminished by glibenclamide. In contrast, glibenclamide did not affect the maximal hypotensive or vasodilator effects of L-S-nitrosocysteine or the duration of these responses. These results suggest that the hypotensive and vasodilator actions of peroxynitrite in anesthetized rats involve the activation of K+ATP-channels whereas the hemodynamic actions of L-S-nitrosocysteine do not.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220073     DOI: 10.1097/01.fjc.0000181715.02452.97

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?

Authors:  Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 2.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

3.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

4.  L-beta,beta-dimethylcysteine attenuates the haemodynamic responses elicited by systemic injections of peroxynitrite in anaesthetized rats.

Authors:  Jonathan E Graves; Neil W Kooy; Stephen J Lewis
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

5.  Potential Benefits of Peroxynitrite.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Open Pharmacol J       Date:  2008

6.  Dual-Channel Fluorescent Probe for the Simultaneous Monitoring of Peroxynitrite and Adenosine-5'-triphosphate in Cellular Applications.

Authors:  Luling Wu; Jihong Liu; Xue Tian; Robin R Groleau; Beidou Feng; Yonggang Yang; Adam C Sedgwick; Hai-Hao Han; Yang Wang; Han-Min Wang; Fang Huang; Steven D Bull; Hua Zhang; Chusen Huang; Yi Zang; Jia Li; Xiao-Peng He; Ping Li; Bo Tang; Tony D James; Jonathan L Sessler
Journal:  J Am Chem Soc       Date:  2021-12-21       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.